Today's Date: June 23, 2024
Maximus Named a Top Washington-Area Workplace by The Washington Post   •   Chinatown Storytelling Centre Opens New Exhibit: Neighbours: From Pender to Hastings   •   Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas   •   Lexus & Amazon Music Present "Destination .Paak - The Lexus GX Remix" on World Music Day   •   Statement by the Prime Minister on National Indigenous Peoples Day   •   Otipemisiwak Métis Government Celebrates the Opening and Ribbon Cutting of Salay Prayzaan Solar Farm   •   Statement by ministers Pascale St-Onge, Gary Anandasangaree, Patty Hajdu and Dan Vandal on National Indigenous Peoples Day   •   SCOTUS Ruling in Rahimi Case Upholds Protections for Domestic Violence Survivors, BWJP Experts Celebrate   •   Daylu Dena Council celebrates grand opening of multi-purpose building in Lower Post, British Columbia   •   Media Advisory: Arvest Bank Awards $15,000 CARE Award to University District Development Corp.   •   WORK BEGINS ON THE ANWATAN-MIGUAM PROJECT IN VAL-D'OR   •   New Research Indicates the Need for Diabetes Continuous Glucose Monitoring to Address Health Disparities   •   Shop, Sip, and Support Social Justice Programs at Five Keys Furniture Annex in Stockton, California, on Saturday, June 22nd from   •   Susan G. Komen® Warns of Dire Impact from Braidwood Management, Inc. et al. v. Xavier Becerra et al. Ruling That Will Force   •   Freedmen’s Town Community Investment Initiative Launches   •   Lifezone Metals Announces Voting Results from its 2024 Annual General Meeting   •   Fairness for Indigenous Peoples in Nova Scotia   •   Produced by Renegade Film Productions/Chameleon Multimedia, Obscure Urban Legend ‘Sweaty Larry’ to Be Invoked for Fi   •   Statement - Mishkeegogamang Ojibway First Nation celebrates community development achievements and National Indigenous Peoples D   •   Government of Canada supports high school students across Canada in developing projects to promote healthy living in their schoo
Bookmark and Share

LaVoieHealthScience Awarded Best Pharma Product Launch at 2024 PRWeek Healthcare Awards

BOSTON & NEW YORK , May 22 /Businesswire/ - LaVoieHealthScience (LHS) is honored to be awarded with the prestigious title of "Best Pharma Product Launch (Non-OTC)” at this year’s PRWeek Healthcare Awards on May 21. This award is for the partnership with Menarini Stemline from the 2023 launch of ORSERDU® (elacestrant) for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.

The award-winning product launch, which focused on increasing visibility and on-label education of ORSERDU®, the first oral selective estrogen receptor modulator (SERD), approved for marketing in the US in January 2023. The combined teams’ communication efforts highlight the impactful collaboration between Menarini Stemline and LaVoieHealthScience.

Donna L. LaVoie, President and CEO of LaVoieHealthScience, expressed her gratitude and pride in the teams’ achievement: "We are immensely proud of our team's hard work and dedication to the 'why' behind this important project. This recognition from PRWeek Healthcare Awards underscores our commitment to excellence in healthcare communications and our dedication to improving patient outcomes. Our commercial practice PR account team, both past and present, played an important role in bringing the first endocrine innovation in 20 years, addressing ESR1 mutations, a major unmet need.”

The PRWeek Healthcare Awards is renowned for celebrating the best of the best in healthcare public relations, recognizing firms that drive the industry forward through innovative and creative strategies.

LaVoieHealthScience extends its thanks to the team at Menarini Stemline for entrusting us with the opportunity to be part of such significant and impactful work. This award is a shared success, reflecting the synergy and collaboration between our organizations. Read our case study with Menarini Stemline here.

About LaVoieHealthScience

LaVoieHealthScience partners with health and science emerging and commercial organizations to advance their innovations. The complexity of the business of science, medicine, and technology requires leaders to create a unique voice in a highly regulated industry. We guide leaders using our 20+ years of history with modern perspectives and time-tested results. Our programs include strategic positioning, public relations and marketing, investor relations, corporate communications, and digital and creative services. For more information, please visit and connect with us on LinkedIn, X, Facebook.

STORY TAGS: United States, North America, New York, Massachusetts, Award, Men, Research, Pharmaceutical, Oncology, Consumer, Public Relations/Investor Relations, Science, Marketing, Advertising, Biotechnology, Women, Communications, Health,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News